UX111

· Ultragenyx Pharmaceutical Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UX111, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIA [Phase 3]